McKesson To Pay $151M To Settle States' Drug Pricing Claims

Law360, New York (July 27, 2012, 8:46 PM EDT) -- Drug wholesaler McKesson Corp. will pay $151 million in a settlement with 29 U.S. states and the District of Columbia over claims that it fraudulently inflated pricing information for several brand-name prescription drugs by as much as 25 percent, causing Medicaid to overpay for reimbursements, several state attorneys general announced Friday.

The agreement resolves allegations that McKesson deliberately inflated the average wholesale price of more than 1,400 brand-name drugs it reported to First Databank Inc., a publisher of drug prices used by many states — including...
To view the full article, register now.